Novo Nordisk Wins Approval For Its Weight-Loss Drug From China
June 25, 2024 at 11:41 AM EDT
China approved the sale of Novo Nordisk's Wegovy on Tuesday. The drugmaker also announced a $4.1 billion investment in the U.S. Novo Nordisk stock climbed 3.0% to an all-time high this morning.
